Capital Fund Management S.A. Enanta Pharmaceuticals Inc Transaction History

Capital Fund Management S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$40.22 - $62.0 $489,678 - $754,850	-12,175 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$57.95 - $66.61 $241,941 - $278,096	4,175 Added 52.19%	12,175 $752,000
Q3 2019 Nov 13, 2019	BUY	$60.08 - $88.17 $108,144 - $158,706	1,800 Added 29.03%	8,000 $481,000
Q2 2019 Aug 12, 2019	BUY	$81.3 - $97.35 $504,060 - $603,570	6,200 New	6,200 $523,000
Q4 2018 Feb 13, 2019	SELL	$65.41 - $84.65 $268,181 - $347,065	-4,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $350,386 - $518,117	4,100 New	4,100 $350,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $198M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.